BioMarin Pharmaceutical income from continuous operations for the twelve months ending September 30, 2024 was $0.322B, a 119.21% increase year-over-year.
BioMarin Pharmaceutical annual income from continuous operations for 2023 was $0.168B, a 18.43% increase from 2022.
BioMarin Pharmaceutical annual income from continuous operations for 2022 was $0.142B, a 320.91% decline from 2021.
BioMarin Pharmaceutical annual income from continuous operations for 2021 was $-0.064B, a 107.5% decline from 2020.
BioMarin Pharmaceutical Income from Continuous Operations 2010-2024 | BMRN